EMA EMA recommends five new medicines, including a first-in-class small interfering RNA treatment Five new medicines are recommended for approval; a further nine medicines are recommended for extension of their therapeutic indications
Long COVID Long COVID could cost as much as €115 billion per year An OECD report finds long COVID will continue to strain health systems and cut productivity, urging better care and cross-sector coordination to reduce its lasting economic impact
COVID-19 Belgian court ruling triggers vaccine blame game in Poland and Romania A Brussels court rules both Poland and Romania must honour binding vaccine contracts signed during the pandemic
mRNA BioNTech co-founders leave to focus on next-generation mRNA innovation Husband-and-wife team who transformed BioNTech into a global vaccine leader are leaving to pioneer the next wave of mRNA disruptors
European Medicines Agency EMA approves 12 medicines including combined COVID-19 and influenza vaccine New combined vaccine could simplify annual vaccine updates
Preparedness Europe invests €240 million in ten-year pandemic preparedness research The European Commission and national partners launch a €240 million decade-long research alliance to strengthen preparedness for future pandemics.
Inside EU Health Inside EU Health: ECDC calls for uptake of flu vaccination; the UK concludes part two of Covid inquiry; vaccines and the fight against AMR ECDC urges immediate uptake of flu vaccination; ‘too little, too late’ - the UK concludes the second report of the Covid inquiry; vaccines and the fight against AMR
COVID ‘Too little, too late’ - the UK concludes the second part of its Covid inquiry The UK’s second report on the Covid inquiry has emerged with 19 recommendations to guide government thinking
Vaccines EU jointly procures Spanish COVID-19 vaccines for winter Europe buys four million doses of protein-based COVID-19 vaccines developed and made in Europe
